Literature DB >> 9381369

Ocular immunopathology of Behçet's disease.

R K George1, C C Chan, S M Whitcup, R B Nussenblatt.   

Abstract

A patient developed progressive, severe, recurrent bilateral iridocyclitis, retinal vasculitis, and hemorrhagic infarction of the retina that led to blindness despite immunosuppressive therapy. Histopathology of an enucleated blind and painful eye revealed marked nongranulomatous uveitis with a predominantly CD4+ T-lymphocytic infiltration, as well as B-cell and plasma cell aggregation. Extensive expression of adhesion molecules on vascular endothelial cells were found. This finding suggests that adhesion molecules play an important role in the vasculitic process, the trademark of Behçet's disease. The ocular pathology and the therapeutic approach to Behçet's disease are briefly reviewed.

Entities:  

Mesh:

Year:  1997        PMID: 9381369     DOI: 10.1016/s0039-6257(97)00026-x

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  20 in total

1.  Fluorescein and indocyanine green angiography findings in Behçet's disease.

Authors:  L S Atmaca; P A Sonmez
Journal:  Br J Ophthalmol       Date:  2003-12       Impact factor: 4.638

2.  Clinical course of patients with Behçet's uveitis following discontinuation of infliximab therapy.

Authors:  Tatsushi Kawaguchi; Yuko Kawazoe; Koju Kamoi; Masaru Miyanaga; Hiroshi Takase; Sunao Sugita; Manabu Mochizuki
Journal:  Jpn J Ophthalmol       Date:  2013-10-16       Impact factor: 2.447

3.  Interferon-beta and adhesion molecules (E-selectin and s-intracellular adhesion molecule-1) are detected in sera from patients with retinal vasculitis and are induced in retinal vascular endothelial cells by Toll-like receptor 3 signalling.

Authors:  M T Lee; L C Hooper; L Kump; K Hayashi; R Nussenblatt; J J Hooks; B Detrick
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

4.  Serum IL-4, IL-12, IL-13, IL-27, and IL-33 levels in active and inactive ocular Behcet's disease.

Authors:  Abdullah Kursat Cingu; Fatih Mehmet Turkcu; Serdar Aktas; Alparslan Sahin; Orhan Ayyildiz
Journal:  Int Ophthalmol       Date:  2020-07-29       Impact factor: 2.031

5.  Long-term efficacy of infliximab on background vascular leakage in patients with Behçet's disease.

Authors:  H Keino; A A Okada; T Watanabe; W Taki
Journal:  Eye (Lond)       Date:  2014-06-20       Impact factor: 3.775

6.  Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system.

Authors:  Hae Min Kang; Sung Chul Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-05-07       Impact factor: 3.117

7.  Quantitative analysis of retinal microcirculation in optical coherence tomography angiography in cases with Behçet's disease without ocular involvement.

Authors:  Ayşegül Çömez; Abdullah Beyoğlu; Yalçın Karaküçük
Journal:  Int Ophthalmol       Date:  2019-03-15       Impact factor: 2.031

8.  The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis.

Authors:  H G Yu; D S Lee; J M Seo; J K Ahn; Y S Yu; W J Lee; H Chung
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

9.  Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.

Authors:  H Yang; S Zheng; Y Mao; Z Chen; C Zheng; H Li; C Sumners; Q Li; P Yang; B Lei
Journal:  Clin Exp Immunol       Date:  2015-11-17       Impact factor: 4.330

Review 10.  A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis.

Authors:  Lei Zhu; Binyao Chen; Wenru Su
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.